Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05401084 · ClinicalTrials.gov registry record · NA
Diet in the Management of Acromegaly
A NA study of Acromegaly, sponsored by Cedars-Sinai Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT05401084 is a NA study of Acromegaly that is actively recruiting participants, run by Cedars-Sinai Medical Center. The registered enrollment target is 9 participants, below the 100-participant average among 13 other Acromegaly trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05401084, a NA study of Acromegaly, is actively recruiting participants, sponsored by Cedars-Sinai Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
Impact of low carbohydrate and low gluten diet on acromegaly progression, symptoms, complications, and treatment outcomes.
Conditions Studied
Interventions
- OTHER Diet
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2024-09-20 |
| Est. Completion | 2025-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05401084
The ClinicalTrials.gov registry entry for NCT05401084 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 13 other Acromegaly trials with a reported enrollment target (91% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acromegaly appearing as the primary indexed condition, and to 1 intervention - of which Diet is the first listed.
NCT05401084 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05401084 about?
NCT05401084 is a clinical study titled "Diet in the Management of Acromegaly". Impact of low carbohydrate and low gluten diet on acromegaly progression, symptoms, complications, and treatment outcomes.
What is the current status of trial NCT05401084?
This trial is currently recruiting. It is a NA study. The enrollment target is 9 participants. The study started on 2024-09-20. Estimated completion is 2025-03-01.
What conditions does trial NCT05401084 study?
This clinical trial studies the following conditions: Acromegaly.
What interventions are being tested in trial NCT05401084?
The interventions under investigation include: Diet (OTHER).
Who is sponsoring clinical trial NCT05401084?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05401084 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acromegaly
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
COMPLETED · NA
-
ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
RECRUITING · Phase 3
-
Study of MAR002 in Healthy Men
RECRUITING · Phase 1
-
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
ACTIVE NOT RECRUITING
-
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.